The AlphaLISA™ SureFire® Ultra™ Human and Mouse High Specificity Total SMAD3 assay is a sandwich immunoassay for quantitative detection of total SMAD3 in cellular lysates using Alpha Technology.
| Feature | Specification |
|---|---|
| Application | 細胞シグナル伝達 |
| Protocol Time | 2h at RT |
| Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Ultra™ Human and Mouse High Specificity Total SMAD3 assay is a sandwich immunoassay for quantitative detection of total SMAD3 in cellular lysates using Alpha Technology.
SMAD3 is an intracellular signal transducer and transcription factor that mediates TGF-β and activin signaling to regulate cell growth, differentiation, and extracellular matrix production. Upon TGF-β receptor activation, SMAD3 is phosphorylated, enabling formation of complexes with SMAD4 that translocate to the nucleus. The SMAD3/SMAD4 complex regulates transcription of genes including collagens, fibronectin, and cyclin-dependent kinase inhibitors. SMAD3 plays context-dependent roles as both a tumor suppressor and tumor promoter. Loss of SMAD3 contributes to colorectal cancer, while excessive SMAD3 activation drives pathological fibrosis in multiple organs.
The AlphaLISA SureFire Ultra Human and Mouse High Specificity Total SMAD3 is a sandwich immunoassay for the quantitative detection of total SMAD3 in cellular lysates, using Alpha Technology.
Formats:
AlphaLISA SureFire Ultra kits are compatible with:
AlphaLISA SureFire Ultra kits can be used for:
The Total-AlphaLISA SureFire Ultra assay measures the expression level of a protein target in a cell lysate.
The Total-AlphaLISA SureFire Ultra assay uses two antibodies which recognize two different distal epitopes on the targeted protein. AlphaLISA assays require two bead types: Acceptor and Donor beads. Acceptor beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor beads are coated with streptavidin to capture one of the detection antibodies, which is biotinylated. In the presence of targeted protein, the two antibodies bring the Donor and Acceptor beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor bead, allowing the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.
The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Ultra detection reagents. This protocol permits the cells viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.
Detection of Total target protein with AlphaLISA SureFire Ultra reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining AlphaLISA SureFire Ultra quality.
A549 and HeLa cells were seeded in a 96-well plate (40,000 cells/well) in complete medium, and incubated overnight at 37°C, 5% CO2. The cells were starved for 1 hour and then treated with increasing concentrations of TGF-β for 90 minutes.
After treatment, the cells were lysed with 200 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). SMAD3 Phospho (Ser423/425) and Total levels were evaluated using AlphaLISA SureFire Ultra High Specificity assays. For the detection step, 10 µL of cell lysate (approximately 2,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, TGF-β triggered a dose-dependent increase in the levels of SMAD3 Phospho (Ser423/425) while Total levels remained unchanged.
SMAD3 Total protein levels were assessed in A549 wild type (WT) and SMAD3 KO (Abcam, ab263915) cell lines cultured to confluency in T175 flasks.
Each flask was lysed in 4 mL of Lysis Buffer for 10 minutes at RT with shaking. Lysates were serially diluted in Lysis Buffer and evaluated for SMAD3 Total using the AlphaLISA SureFire Ultra High Specificity assay. For the detection step, 10 µL of cell lysate (approximately 12,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
SMAD3 Total was only detected in WT cells, demonstrating assay specificity.
Adherent cells were grown to confluency in a T175 flask at 37°C, 5% CO2, and were lysed with Lysis Buffer at a density of 1 x 106 cells/mL. Suspension cells were harvested, washed in HBSS and lysed with Lysis Buffer at 3.2 x 106 cells/mL.
SMAD3 Total levels were evaluated using the AlphaLISA SureFire Ultra High Specificity assay. For the detection step, 10 µL of cell lysate (10,000 adherent and 32,000 suspension cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
SMAD3 Total expression was detected in a wide range of human and mouse cell lines.
Cell lysate was prepared from RAW 264.7 cells cultured to confluence in a T175 flask and stimulated with 50 ng/mL TGF-β for 90 minutes. Cells were lysed with 6 mL Lysis Buffer for 10 minutes at RT with shaking.
Lysate was serially diluted in Lysis Buffer and SMAD3 Phospho (Ser423/425) and Total levels were evaluated using AlphaLISA SureFire Ultra High Specificity assays. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
Approximate number of cells per datapoint is indicated. The dotted line represents assay background. The assay can detect SMAD3 Total down to 2,500 cells/datapoint.
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA SureFire Ultra
|
| Detection Modality |
Alpha
|
| Product Group |
Kit
|
| Protocol Time |
2h at RT
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
SMAD3
|
| Target Class |
Phosphoproteins
|
| Target Species |
Human
Mouse
|
| Technology |
Alpha
|
| Therapeutic Area |
Inflammation
NASH/Fibrosis
Oncology
|
| Unit Size |
500 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
Alpha technolgy enables the rapid and straightforward mesaure of virtually any target. This includes enzymes, receptor-ligand...
The definitive guide for setting up a successful AlphaLISA SureFire Ultra assay
Several biological processes are regulated by...
Discover Alpha SureFire® Ultra™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology...
This document includes detailed tables listing HTRF™, AlphaLISA™ SureFire® Ultra™, and Alpha SureFire® Ultra™ Multiplex assays...
We are here to answer your questions.